These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 23079386)

  • 41. PAX3/FOXO1 fusion gene status is the key prognostic molecular marker in rhabdomyosarcoma and significantly improves current risk stratification.
    Missiaglia E; Williamson D; Chisholm J; Wirapati P; Pierron G; Petel F; Concordet JP; Thway K; Oberlin O; Pritchard-Jones K; Delattre O; Delorenzi M; Shipley J
    J Clin Oncol; 2012 May; 30(14):1670-7. PubMed ID: 22454413
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Results of a prospective minimal disseminated disease study in human rhabdomyosarcoma using three different molecular markers.
    Sartori F; Alaggio R; Zanazzo G; Garaventa A; Di Cataldo A; Carli M; Rosolen A;
    Cancer; 2006 Apr; 106(8):1766-75. PubMed ID: 16544315
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dense pattern of embryonal rhabdomyosarcoma, a lesion easily confused with alveolar rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
    Rudzinski ER; Teot LA; Anderson JR; Moore J; Bridge JA; Barr FG; Gastier-Foster JM; Skapek SX; Hawkins DS; Parham DM
    Am J Clin Pathol; 2013 Jul; 140(1):82-90. PubMed ID: 23765537
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Examination of gene fusion status in archival samples of alveolar rhabdomyosarcoma entered on the Intergroup Rhabdomyosarcoma Study-III trial: a report from the Children's Oncology Group.
    Barr FG; Smith LM; Lynch JC; Strzelecki D; Parham DM; Qualman SJ; Breitfeld PP
    J Mol Diagn; 2006 May; 8(2):202-8. PubMed ID: 16645206
    [TBL] [Abstract][Full Text] [Related]  

  • 45. PAX3/7-FOXO1 fusion status in older rhabdomyosarcoma patient population by fluorescent in situ hybridization.
    Dumont SN; Lazar AJ; Bridge JA; Benjamin RS; Trent JC
    J Cancer Res Clin Oncol; 2012 Feb; 138(2):213-20. PubMed ID: 22089931
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cytogenetic and molecular findings related to rhabdomyosarcoma. An analysis of seven cases.
    Gil-Benso R; López-Ginés C; Carda C; López-Guerrero JA; Ferrer J; Pellín-Pérez A; Llombart-Bosch A
    Cancer Genet Cytogenet; 2003 Jul; 144(2):125-33. PubMed ID: 12850375
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rhabdomyosarcoma: value of myogenin expression analysis and molecular testing in diagnosing the alveolar subtype: an analysis of 109 paraffin-embedded specimens.
    Hostein I; Andraud-Fregeville M; Guillou L; Terrier-Lacombe MJ; Deminière C; Ranchère D; Lussan C; Longavenne E; Bui NB; Delattre O; Coindre JM
    Cancer; 2004 Dec; 101(12):2817-24. PubMed ID: 15536621
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Diffuse myogenin expression by immunohistochemistry is an independent marker of poor survival in pediatric rhabdomyosarcoma: a tissue microarray study of 71 primary tumors including correlation with molecular phenotype.
    Heerema-McKenney A; Wijnaendts LC; Pulliam JF; Lopez-Terrada D; McKenney JK; Zhu S; Montgomery K; Mitchell J; Marinelli RJ; Hart AA; van de Rijn M; Linn SC
    Am J Surg Pathol; 2008 Oct; 32(10):1513-22. PubMed ID: 18708938
    [TBL] [Abstract][Full Text] [Related]  

  • 49. High IGFBP2 expression correlates with tumor severity in pediatric rhabdomyosarcoma.
    Tombolan L; Orso F; Guzzardo V; Casara S; Zin A; Bonora M; Romualdi C; Giorgi C; Bisogno G; Alaggio R; Pinton P; De Pittà C; Taverna D; Rosolen A; Lanfranchi G
    Am J Pathol; 2011 Nov; 179(5):2611-24. PubMed ID: 21924226
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nephroblastoma overexpressed (NOV/CCN3) gene: a paired-domain-specific PAX3-FKHR transcription target that promotes survival and motility in alveolar rhabdomyosarcoma cells.
    Zhang Y; Wang C
    Oncogene; 2011 Aug; 30(32):3549-62. PubMed ID: 21423212
    [TBL] [Abstract][Full Text] [Related]  

  • 51. OLIG2 is a novel immunohistochemical marker associated with the presence of PAX3/7-FOXO1 translocation in rhabdomyosarcomas.
    Kaleta M; Wakulińska A; Karkucińska-Więckowska A; Dembowska-Bagińska B; Grajkowska W; Pronicki M; Łastowska M
    Diagn Pathol; 2019 Sep; 14(1):103. PubMed ID: 31493794
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Alveolar rhabdomyosarcoma-associated proteins PAX3/FOXO1A and PAX7/FOXO1A suppress the transcriptional activity of MyoD-target genes in muscle stem cells.
    Calhabeu F; Hayashi S; Morgan JE; Relaix F; Zammit PS
    Oncogene; 2013 Jan; 32(5):651-62. PubMed ID: 22710712
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Embryonal and alveolar rhabdomyosarcoma of parameningeal sites in adults: a report of 13 cases.
    Montone KT; Barr FG; Zhang PJ; Feldman MD; LiVolsi VA
    Int J Surg Pathol; 2009 Feb; 17(1):22-30. PubMed ID: 18945709
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transcriptional regulation of IGF-I receptor gene expression by the PAX3-FKHR oncoprotein.
    Ayalon D; Glaser T; Werner H
    Growth Horm IGF Res; 2001 Oct; 11(5):289-97. PubMed ID: 11735247
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Analysis of genetic events that modulate the oncogenic and growth suppressive activities of the PAX3-FKHR fusion oncoprotein.
    Xia SJ; Rajput P; Strzelecki DM; Barr FG
    Lab Invest; 2007 Apr; 87(4):318-25. PubMed ID: 17297479
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Disruption of imprinted genes at chromosome region 11p15.5 in paediatric rhabdomyosarcoma.
    Anderson J; Gordon A; McManus A; Shipley J; Pritchard-Jones K
    Neoplasia; 1999 Oct; 1(4):340-8. PubMed ID: 10935489
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pax3 loss of function delays tumour progression in kRAS-induced zebrafish rhabdomyosarcoma models.
    Kahsay A; Rodriguez-Marquez E; López-Pérez A; Hörnblad A; von Hofsten J
    Sci Rep; 2022 Oct; 12(1):17149. PubMed ID: 36229514
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Influences of PAX3-FKHR transfection on expression of MRF4 and differentiation of cultured human rhabdomyosarcoma RD cells].
    Li GH; Wang DL; Wang Y; Chen ZT; Li DZ
    Ai Zheng; 2003 Jan; 22(1):30-4. PubMed ID: 12561432
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Minimal disease detection in patients with alveolar rhabdomyosarcoma using a reverse transcriptase-polymerase chain reaction method.
    Kelly KM; Womer RB; Barr FG
    Cancer; 1996 Sep; 78(6):1320-7. PubMed ID: 8826957
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Expression and parental imprinting of the H19 gene in human rhabdomyosarcoma.
    Casola S; Pedone PV; Cavazzana AO; Basso G; Luksch R; d'Amore ES; Carli M; Bruni CB; Riccio A
    Oncogene; 1997 Mar; 14(12):1503-10. PubMed ID: 9136994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.